-+ 0.00%
-+ 0.00%
-+ 0.00%

LIXTE BIOTECHNOLOGY PROVIDES UPDATE ON PROGRESS WITH PROPRIETARY COMPOUND, LB-100, TO TREAT OVARIAN AND COLORECTAL CANCER

Reuters·03/27/2025 12:30:01

Please log in to view news